Overview

Efficacy and Safety of Nitrazine in the Treatment of ALS

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the trend of safety and effectiveness of Nitroketazine tablets for ALS patients, and to explore the best effective dose.
Phase:
Phase 2
Details
Lead Sponsor:
Peking University Third Hospital
Collaborator:
West China Hospital
Treatments:
Nitrofurazone